Related Experiment Video
Updated: Mar 18, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Definition of a Skp2-c-Myc Pathway to Expand Human Beta-cells
Shiwani Tiwari1, Chris Roel1, Mansoor Tanwir2
1Diabetes Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Abstract:
Type 2 diabetes (T2D) is characterized by insulin resistance and reduced functional β-cell mass. Developmental differences, failure of adaptive expansion and loss of β-cells via β-cell death or de-differentiation have emerged as the possible causes of this reduced β-cell mass. We hypothesized that the proliferative response to mitogens of human β-cells from T2D donors is reduced, and that this might contribute to the development and progression of T2D. Here, we demonstrate that the proliferative response of human β-cells from T2D donors in response to cdk6 and cyclin D3 is indeed dramatically impaired. We show that this is accompanied by increased nuclear abundance of the cell cycle inhibitor, p27(kip1). Increasing nuclear abundance of p27(kip1) by adenoviral delivery decreases the proliferative response of β-cells from non-diabetic donors, mimicking T2D β-cells. However, while both p27(kip1) gene silencing and downregulation by Skp2 overexpression increased similarly the proliferative response of human β-cells, only Skp2 was capable of inducing a significant human β-cell expansion. Skp2 was also able to double the proliferative response of T2D β-cells. These studies define c-Myc as a central Skp2 target for the induction of cell cycle entry, expansion and regeneration of human T2D β-cells.
Insights
Type 2 diabetes (T2D) is linked to reduced human beta-cell proliferation. Skp2 protein enhances beta-cell expansion and regeneration in T2D by targeting c-Myc, offering a potential therapeutic strategy.
Area of Science:
- Endocrinology
- Cell Biology
- Molecular Medicine
Background:
- Type 2 diabetes (T2D) is characterized by insulin resistance and diminished functional beta-cell mass.
- Reduced beta-cell mass in T2D may result from developmental issues, impaired adaptive expansion, or beta-cell death/de-differentiation.
Purpose of the Study:
- To investigate the hypothesis that human beta-cells from T2D donors exhibit a reduced proliferative response to mitogens.
- To explore the role of cell cycle regulators in T2D beta-cell dysfunction and identify potential targets for beta-cell regeneration.
Main Methods:
- Assessed the proliferative response of human beta-cells from T2D and non-diabetic donors to specific mitogens (cdk6 and cyclin D3).
- Investigated the role of the cell cycle inhibitor p27(kip1) and the E3 ubiquitin ligase Skp2 in regulating beta-cell proliferation.
- Utilized adenoviral delivery for gene manipulation and measured beta-cell expansion and proliferation rates.
Main Results:
- Human beta-cells from T2D donors showed a significantly impaired proliferative response to cdk6 and cyclin D3.
- Increased nuclear abundance of p27(kip1) was observed in T2D beta-cells, and its overexpression inhibited proliferation in non-diabetic beta-cells.
- Skp2 overexpression, unlike p27(kip1) silencing, effectively promoted human beta-cell expansion and significantly enhanced T2D beta-cell proliferation.
- c-Myc was identified as a key Skp2 target essential for initiating cell cycle entry and promoting beta-cell expansion and regeneration.
Conclusions:
- The impaired proliferative capacity of beta-cells contributes to the pathogenesis of T2D.
- Skp2 plays a critical role in beta-cell expansion and regeneration, potentially through c-Myc regulation.
- Targeting the Skp2-c-Myc pathway represents a promising strategy for regenerating beta-cells in T2D.
More Related Videos
10:12Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
TGF - β Signaling Pathway